INSP - Company ID 0001609550
The table below shows Inspire Medical Systems, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $12.85M | -$6.70M | $8.86M | -$1.34M | -$12.75M | -$10.40M |
| Capital expenditure | $9.73M | $8.41M | $11.70M | $3.75M | $1.22M | $1.32M |
| Investing cash flow | -$11.25M | -$1.55M | -$19.54M | -$3.75M | -$1.47M | -$1.32M |
| Dividends paid | - | - | - |
Inspire Medical Systems, Inc. reported operating cash flow of $116.98M for fiscal year 2025. That is down 10.2% from $130.25M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$17.95M (FY 2016) to $116.98M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | $0.00 | $75.01M | $0.00 | - | - | - |
| Financing cash flow | -$7.48M | -$87.76M | $768.00K | $5.63M | $3.04M | $3.55M |